MalarVx, Inc.
Home
ABOUT
The challenge
The Disease – Malaria
The Team
R&D
Vaccine Development
In vitro mosquito-stages
Pipeline
Publications
News
Contact
Citations
June 2025
MalarVx licenses HDT Bio’s repRNA/LION™ Technology for Novel Malaria Vaccine
By
Marion Avril
|
4
Jun, 25
|
